Study suggests that inhaled treatment may alleviate more severe cases of Covid-19.
The drug SNG001 uses a natural protein and is expected to revolutionize the way hospitalized patients are treated.
Jacqueline Saraiva, Metrópoles - The results are still preliminary, but a study released by the laboratory... SynairgenA study released this Monday (July 20th) indicates that a drug would reduce the risk of developing a severe form of the new coronavirus, which causes Covid-19, by 79%.
Titled SNG001The treatment is inhaled and uses interferon beta, a natural protein involved in the body's response when invaded by viruses. The drug will still undergo peer review by the scientific community, but It could revolutionize the way Covid-19 is treated..
Read more on Metropolis.